Department of Biophysics, Molecular Biology and Bioinformatics, University of Calcutta, Kolkata, 700009, India.
Bugworks Research India Pvt. Ltd, C-CAMP, NCBS Campus, UAS-GKVK, Bellary Road, Bangalore, 560065, India.
Biotechnol Lett. 2019 Jul;41(6-7):675-688. doi: 10.1007/s10529-019-02678-2. Epub 2019 Apr 29.
Core biochemical pathways such as Fatty-acid synthesis II (FAS II) is ascribed to the synthesis of fatty-acids, biotin and lipoic acid in prokaryotes. It has two dehydrogenases namely, FabG and FabI which interact with the fatty-acid chain bound to Acyl-carrier protein (ACP), a well-studied enzyme which binds to substrates of varying lengths. This protein-protein interaction 'broadens' the active site of these dehydrogenases thus, contributing to their flexible nature. This property is exploited for catalysing numerous chiral synthons, alkanes, long-chain alcohols and secondary metabolites in industries especially with FabG. FASI relegates FASII in eukaryotes making it a 'relic gene pool' and an antibacterial drug target with diverse inhibitor and substrate markush. FabG often substitutes other dehydrogenases for producing secondary metabolites in nature. This redundancy is probably due to gene duplication or addition events possibly making FabG, a progenitor to some of the complex short-chain dehydrogenases used in organisms and industries today.
核心生化途径,如脂肪酸合成 II(FAS II),归因于原核生物中脂肪酸、生物素和硫辛酸的合成。它有两个脱氢酶,即 FabG 和 FabI,它们与与酰基载体蛋白(ACP)结合的脂肪酸链相互作用,ACP 是一种研究充分的酶,可与不同长度的底物结合。这种蛋白质-蛋白质相互作用“拓宽”了这些脱氢酶的活性位点,从而使其具有灵活性。这种特性被用于催化众多手性前体、烷烃、长链醇和次级代谢物,尤其是 FabG 在工业中的应用。FASI 将 FASII 置于真核生物中,使其成为一个“遗留基因库”,并具有多样化的抑制剂和底物标记,成为抗菌药物的靶标。FabG 经常取代其他脱氢酶来在自然界中产生次级代谢物。这种冗余可能是由于基因复制或添加事件导致的,这可能使 FabG 成为当今生物和工业中一些复杂的短链脱氢酶的前体。